Morningstar Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Hold
3,226
0.03% 273
2026
Q1
$450K Sell
3,226
-665
-17% -$93.1K 0.03% 271
2025
Q4
$478K Sell
3,891
-1,431
-27% -$174K 0.03% 274
2025
Q3
$591K Sell
5,322
-7,248
-58% -$824K 0.02% 414
2025
Q2
$1.39M Sell
12,570
-321
-2% -$34.2K 0.12% 49
2025
Q1
$1.44M Sell
12,891
-2,212
-15% -$228K 0.12% 45
2024
Q4
$1.4M Sell
15,103
-653
-4% -$58.8K 0.11% 53
2024
Q3
$1.34M Buy
15,756
+153
+1% +$11.7K 0.13% 71
2024
Q2
$1.07M Hold
15,603
0.11% 76
2024
Q1
$1.14M Hold
15,603
0.12% 75
2023
Q4
$1.26M Sell
15,603
-396
-2% -$30.8K 0.15% 71
2023
Q3
$1.2M Buy
15,999
+751
+5% +$57.8K 0.16% 49
2023
Q2
$1.18M Buy
15,248
+10,100
+196% +$806K 0.16% 51
2023
Q1
$427K Hold
5,148
0.06% 63
2022
Q4
$442K Buy
+5,148
New +$408K 0.07% 58

Other funds holding GILD

Morningstar Investment Management's GILD Position: Q2 2026 in Review

Morningstar Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,226 shares worth $450K. The position accounts for 0.03% of the portfolio, ranked #273.

Morningstar Investment Management first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.44M in Q1 2025. 1,236 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Morningstar Investment Management held 3,226 shares of Gilead Sciences worth $450K as of Q2 2026.
  • Morningstar Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of Morningstar Investment Management's portfolio in Q2 2026, its #273 holding.
  • Morningstar Investment Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Morningstar Investment Management's Gilead Sciences position peaked at $1.44M in Q1 2025.
  • 1,236 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.